Bio­gen CSO Ar­ta­va­nis-Tsakonas heads back to Har­vard, lab fund­ing in hand

Al­most ex­act­ly four years af­ter be­ing named per­ma­nent chief sci­en­tif­ic of­fi­cer at Bio­gen, Spy­ros Ar­ta­va­nis-Tsakonas has now qui­et­ly left the com­pa­ny, ac­cord­ing to a re­port in the Boston Busi­ness Jour­nal.

The cell bi­ol­o­gy spe­cial­ist has been a pro­fes­sor at Har­vard Med­ical School since 1999. And now he’s head­ed back with fund­ing from Bio­gen on new re­search in­to neu­rode­gen­er­a­tive dis­eases. The big biotech gets an op­tion on li­cens­ing new tech from his lab in ex­change for the fund­ing, ac­cord­ing to the BBJ, which cit­ed Bio­gen’s proxy state­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.